ViruSure, an Asahi Kasei company and global leader in pathogen safety testing for biopharmaceuticals, today announced the launch of the world's first GMP-validated adventitious viral agent (AVA) ...

Shares in Oxford Nanopore Technologies fell sharply in morning trading on Monday, after the FTSE 250 firm lowered its ...

Chief Financial Officer Nick Keher outlined the company’s progress in expanding beyond its historically research-led revenue base, highlighting rapid growth in clinical and applied industrial end ...

A team of scientists led by the University of Oxford have achieved a significant breakthrough in detecting modifications on protein structures. The method, published in Nature Nanotechnology, employs ...

Barclays 28th Annual Global Healthcare Conference March 11, 2026 3:30 PM EDTCompany ParticipantsNicholas Keher ...

Looking ahead, Oxford Nanopore said for 2026 it expects revenue to grow by between 21% and 25% on a constant currency basis. Back in September, the firm guided for over 30% revenue growth between 2024 ...

Oxford Nanopore Technologies (LON:ONT) used its FY 2025 results call to outline a leadership transition, review a year of growth and cost control, and provide guidance for 2026 alongside commentary on ...

Analysts at Berenberg lowered their target price on Oxford Nanopore Technologies from 250p to 230p on Monday after the nanopore sequencing products developer released its full-year 2025 results.

Scientists announced DNA storage devices capable of rewriting, erasing, and storing data for centuries ...

The 2026 revenue guidance reflects a deliberate slowdown in its largest region. EMEAI, which grew 26.3% at constant currency ...